BACKGROUND: The main symptoms of myelopathy associated with human T-cell lymphotropic virus type 1 or tropical spastic paraparesis (HAM / TSP) are the presence of high intensity pain in the lower back, spasticity and weakness in the lower limbs, loss of balance and difficulties in locomotion. Pulsed Transcranial Magnetic Stimulation (rTMS) has been able to influence cortical plasticity, decreasing spasticity, increasing motor performance and promoting analgesia in several similar conditions. OBJECTIVE: To analyze the effect of neuromodulation by pulsed transcranial magnetic stimulation (rTMS) on pain and functional mobility in individuals with HAM / TSP. METHODOLOGY: A randomized clinical trial will be conducted in a sample made up of 40 participants randomly allocated into two groups: Sham Group (SG) with 20 and Test Group (TG) with 20 patients. Individuals aged> 20 years, community walkers with or without orthosis, with chronic pain (? 6 months) in the lumbar region and / or lower limbs will be included. Individuals with epilepsy, cancer, pregnant women, patients with cardiac pacemakers, metallic implants in the brain or skull, users of illicit drugs and / or use of controlled medications in the last six months will be excluded. The protocol will be applied for 10 consecutive days with eight months of follow-up. Our hypothesis is that when using rTMs according to the proposed procedure, it will be possible to relieve pain and improve the functional mobility of these individuals with a long-lasting effect. CONCLUSION: We hope that rTMS is a promising treatment to reduce pain intensity and to improve functional mobility in individuals undergoing active modality. We declare this protocol a promising resource for the treatment of htlv-1 individuals in reducing pain and improving functional mobility. Yes, this protocol has already been applied to 6 patients. However, with the pandemic the study had to be discontinued. However, despite the small sample size and not being fully applied as suggested by the protocol, it was possible to notice a satisfactory result of the intervention. Thus, the application of this protocol can contribute to identify the result of this therapeutic modality in a safer way, as well as assist in the treatment of symptoms of this population, favoring a better quality of life.
Introduction: Human T-Cell Lymphotropic Virus (HTLV) is a sexually transmitted retrovirus that can cause chronic pain of moderate to high intensity, spasticity and weakness in the lower limbs, balance, gait, urinary and sexual dysfunctions. Physiotherapy is a treatment that has been shown to be effective in improving symptoms and signs. However, research on the topic is scarce. Objective: Outline the research scenario in Physiotherapy aimed at people infected with HTLV-1. Methods: Scientometric study carried through Medline, Virtual Health Library, Scopus, Web of Science and Google Scholar databases. The metadata regarding the studies were tabulated and analyzed using descriptive statistics. The VOS.Viewer software was used for the analysis of quotes. Clinical studies were also analyzed considering meta-scientific impacts including analysis of conflicts of interest and methodological biases. Results: Initially 1160 studies were identified. After applying the eligibility criteria, 68 articles remained, of which 34 articles were observational studies, 21 on intervention, 9 on review, two on qualitative research and two on diagnostic accuracy. Brazil is responsible for 94.11% of the production on the theme. The sub-areas of Physiotherapy covered by the studies were neurofunctional and urogenital, using different exercise modalities, proprioceptive neuromuscular facilitation, biofeedback and non-invasive neuromodulation. Conclusion: On the topic of Physiotherapy for people with HTLV-1, Brazil occupies a prominent place in scientific production. Research on the subject receives little or no funding, requiring free of charge publications in journals, which affects its visibility.
CONTEXT: Individuals with HTLV-1 have dysfunctions that directly impact their quality of life. Physiotherapy uses resources that help a lot in the treatment of these changes. However, questions are asked about which modalities are most used and whether they are being properly applied. The only certainty is that the more we know about the physical therapy resources used in individuals with HTLV-1, the better the result of the treatment used. How, then, is this scientific scenario?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.